Resources
Highlights from London Calling
Discover how researchers are using Oxford Nanopore sequencing to generate new insights across diverse applications.
)
Discover nanopore sequencing
- What it can do
- How it’s being used
- How to get started
Latest protocols
Hereditary Cancer Panel (HCP)
Nanopore-only Microbial Isolate Sequencing Solution (NO-MISS) – automated ElysION MinION (SQK-RBK114.96)
Long read de novo sequencing from blood and cells using SQK-ULK114 – expert telomere-to-telomere method
Microbial amplicon barcoding for 16S and ITS – automated ElysION MinION (SQK-MAB114.24)
Rapid PCR barcoding DNA V14 – automated ElysION MinION (SQK-RPB114.24)
Rapid barcoding DNA V14 – automated ElysION MinION (SQK-RBK114.96)
Webinars and events
)
Unlocking high-resolution, strain-resolved microbiome analyses | ASM Microbe 26
During this video we learn how full length Oxford Nanopore sequencing is unlocking high-resolution microbiome analyses
)
Oxford Nanopore at AMP 2026
Oxford Nanopore Technologies are exhibiting and presenting at AMP 2026 in November.
White papers
)
Genomics for a changing planet: sequencing the living world
Discover how a global community of researchers are harnessing Oxford Nanopore sequencing to study the far-reaching impacts of climate change, revealing deep insights across environmental research, agriculture, and pathogen surveillance.
)
New approaches for human and clinical research
Explore the advantages of Oxford Nanopore sequencing to detect genomic and epigenomic variants in human and clinical research.
Case studies
)
Pan-microbial pathogen detection in hours using metagenomic sequencing
In this case study, discover how the UK NHS Respiratory Metagenomics Network have developed a rapid Oxford Nanopore sequencing workflow that can detect the bacteria, viruses, fungi, and parasitic pathogens underlying respiratory infections in a matter of hours.
)
Large-cohort cDNA sequencing advances multiomic insights into neurodegenerative disease
In this case study, discover how Kimberley Billingsley and her colleagues at the National Institutes of Health are using Oxford Nanopore large-cohort cDNA sequencing to research the human brain transcriptome, enhancing understanding of the drivers of neurodegenerative diseases.
Getting started guides
)
A guide to biopharma solutions from Oxford Nanopore — from discovery to development
This guide introduces Oxford Nanopore sequencing solutions for biopharma that can be applied from biomarker discovery through to final product quality control (QC) testing.
)
A guide to transcriptomics with Oxford Nanopore
This guide introduces cDNA and direct RNA Oxford Nanopore sequencing, for ultra-rich transcriptomic data without compromise.
Workflow overviews
)
Comprehensive characterisation of cancer predisposition genes using the Hereditary Cancer Panel
Discover the Hereditary Cancer Panel workflow and streamline your precision oncology research.
)
Comprehensive human genomic variant and methylation analysis with long Oxford Nanopore reads
This end-to-end workflow provides a scalable method to identify previously hidden and potentially pathogenic variants.
Brochures
)
Oxford Nanopore sequencing solutions for cell and gene therapies
Discover how Oxford Nanopore technology can support the development of your cell, gene, and RNA therapies.
)
cDNA-PCR Sequencing Kits
In this flyer, discover how you can sequence full-length transcripts and annotate the transcriptome with confidence.
)
Browse document repository
Quickly find the resources most relevant to your work. Filter by application, technique, product, or content type to get straight to the content that matters.
